Today Celgene released 2015 product revenue guidance $100 million above consensus. Celgene guides 2015 product revenue to be $9 billion to $9.5 billion. Consensus for 2015 is for revenue of $9.26 billion, but this is a total revenue estimate. Celgene also has royalty revenue of about $100 million per year. So the mid-point of their 2015 revenue guidance is $9.35 billion. Celgene also sees an increase in adjusted operating margin of about 140 bps.
Celgene also forecasts 2015 adjusted diluted EPS in the range of $4.60 - $4.75. This is slightly below the consensus at $4.86, but the market obviously thought management was being conservative on this because the stock was up 2.9% today with the S&P down -0.8%.
Celgene 2015 guidance released today.
Michael Grove, CFA